Schizophrenia: from mechanism to therapy

Key Points

• Schizophrenia mechanisms involve complex neurotransmitter pathways that impact therapy effectiveness.
• Key associations include changes in dopamine and glutamate levels, which influence treatment outcomes for schizophrenia.
• Analysis of existing pharmacological therapies highlights the need for targeted interventions based on biomarker profiles.
• The findings support novel therapeutic approaches and emphasize the importance of personalized treatment plans for schizophrenia.